Published in Antimicrob Agents Chemother on February 16, 2010
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev (2011) 2.46
Engineering microbial biofuel tolerance and export using efflux pumps. Mol Syst Biol (2011) 1.96
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci U S A (2012) 1.66
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother (2010) 1.30
Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci U S A (2012) 1.25
Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol (2015) 1.08
Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB. Elife (2014) 1.04
Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci U S A (2013) 1.02
Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB. Biochemistry (2013) 0.88
Molecular Dynamics Computer Simulations of Multidrug RND Efflux Pumps. Comput Struct Biotechnol J (2013) 0.87
MexT functions as a redox-responsive regulator modulating disulfide stress resistance in Pseudomonas aeruginosa. J Bacteriol (2012) 0.86
High salt concentrations increase permeability through OmpC channels of Escherichia coli. J Biol Chem (2014) 0.86
β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket. J Biol Chem (2014) 0.85
Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad Sci U S A (2016) 0.81
Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli. J Bacteriol (2015) 0.81
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. Antimicrob Agents Chemother (2016) 0.79
Members of the conserved DedA family are likely membrane transporters and are required for drug resistance in Escherichia coli. Antimicrob Agents Chemother (2013) 0.79
Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Antimicrob Agents Chemother (2014) 0.78
Substrate binding accelerates the conformational transitions and substrate dissociation in multidrug efflux transporter AcrB. Front Microbiol (2015) 0.77
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. Eur J Med Chem (2012) 0.76
Quantitative measurement of the outer membrane permeability in Escherichia coli lpp and tol-pal mutants defines the significance of Tol-Pal function for maintaining drug resistance. J Antibiot (Tokyo) (2016) 0.76
Effect of site-directed mutations in multidrug efflux pump AcrB examined by quantitative efflux assays. Biochem Biophys Res Commun (2016) 0.75
Dynamical Model of Drug Accumulation in Bacteria: Sensitivity Analysis and Experimentally Testable Predictions. PLoS One (2016) 0.75
Modeling the kinetics of the permeation of antibacterial agents into growing bacteria and its interplay with efflux. Antimicrob Agents Chemother (2017) 0.75
Bifurcation kinetics of drug uptake by Gram-negative bacteria. PLoS One (2017) 0.75
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
Micro-iodometric assay for penicillinase. Biochem J (1962) 16.45
High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection. Gene (1987) 9.16
AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol (1996) 8.50
AmpC beta-lactamases. Clin Microbiol Rev (2009) 7.14
Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol (1983) 6.29
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature (2006) 5.35
Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J Bacteriol (1983) 5.20
Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother (1985) 4.88
The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol (1996) 4.56
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob Agents Chemother (1994) 4.43
Microiodometric determination of beta-lactamase activity. Antimicrob Agents Chemother (1972) 4.28
Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science (2006) 4.21
Multidrug resistance in bacteria. Annu Rev Biochem (2009) 3.96
Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Mol Microbiol (1987) 3.93
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
Efflux-mediated antimicrobial resistance. J Antimicrob Chemother (2005) 3.69
Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother (1985) 3.34
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. J Bacteriol (1998) 2.92
Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors. PLoS Biol (2007) 2.89
Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta (2008) 2.60
AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex. J Biol Chem (2004) 2.48
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol (2001) 2.47
The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc Natl Acad Sci U S A (2009) 2.47
Sequence elements determining ampC promoter strength in E. coli. EMBO J (1982) 2.35
A survey of the kinetic parameters of class C beta-lactamases. Penicillins. Biochem J (1988) 2.17
The need for new antibiotics. Clin Microbiol Infect (2004) 1.87
Three's company: component structures bring a closer view of tripartite drug efflux pumps. Curr Opin Struct Biol (2004) 1.84
Isolation and characterization of OmpC porin mutants with altered pore properties. J Bacteriol (1988) 1.66
Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55
Covalently linked trimer of the AcrB multidrug efflux pump provides support for the functional rotating mechanism. J Bacteriol (2008) 1.45
Site-directed disulfide cross-linking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli. J Bacteriol (2007) 1.39
Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams. Antimicrob Agents Chemother (2000) 1.23
Molecular characterization of the OXA-7 beta-lactamase gene. Antimicrob Agents Chemother (1995) 1.16
Cooperativity in enzyme function: equilibrium and kinetic aspects. Methods Enzymol (1995) 1.06
ompC mutants which allow growth on maltodextrins show increased channel size and greater voltage sensitivity. FEBS Lett (1991) 1.01
Efflux-mediated drug resistance in bacteria. Drugs (2004) 3.90
Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science (2003) 3.64
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol (2002) 2.98
The baeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J Bacteriol (2002) 2.46
A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J Bacteriol (2005) 2.35
Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol (2003) 2.18
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01
Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J Bacteriol (2005) 1.78
PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol (2007) 1.70
Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway. J Bacteriol (2006) 1.66
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother (2004) 1.63
AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J Bacteriol (2003) 1.62
Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2009) 1.55
Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A (2010) 1.54
Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump. J Bacteriol (2003) 1.53
Export of autotransported proteins proceeds through an oligomeric ring shaped by C-terminal domains. EMBO J (2002) 1.50
Covalently linked trimer of the AcrB multidrug efflux pump provides support for the functional rotating mechanism. J Bacteriol (2008) 1.45
Site-directed disulfide cross-linking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli. J Bacteriol (2007) 1.39
Threonine-978 in the transmembrane segment of the multidrug efflux pump AcrB of Escherichia coli is crucial for drug transport as a probable component of the proton relay network. J Bacteriol (2006) 1.31
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother (2010) 1.30
Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci U S A (2012) 1.25
Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother (2003) 1.25
Substrate path in the AcrB multidrug efflux pump of Escherichia coli. Mol Microbiol (2010) 1.24
Pseudomonas aeruginosa porin OprF exists in two different conformations. J Biol Chem (2006) 1.22
Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol (2007) 1.21
OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol (2012) 1.09
The C-terminal domain of Salmonella enterica serovar typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surface. Infect Immun (2003) 1.09
Pseudomonas aeruginosa porin OprF: properties of the channel. J Biol Chem (2006) 1.06
Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay. FEBS Lett (2007) 1.05
Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli. J Bacteriol (2011) 1.04
3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm. Drug Resist Updat (2003) 1.02
Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci U S A (2013) 1.02
It takes three to tango. Nat Biotechnol (2002) 0.96
Multidrug efflux pump MdtBC of Escherichia coli is active only as a B2C heterotrimer. J Bacteriol (2009) 0.96
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob Agents Chemother (2013) 0.95
Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides. Proc Natl Acad Sci U S A (2014) 0.93
Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformer. MBio (2010) 0.90
Quantitative lipid composition of cell envelopes of Corynebacterium glutamicum elucidated through reverse micelle extraction. Proc Natl Acad Sci U S A (2011) 0.88
Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB. Biochemistry (2013) 0.88
Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa. FEBS J (2012) 0.85
Site-directed disulfide cross-linking to probe conformational changes of a transporter during its functional cycle: Escherichia coli AcrB multidrug exporter as an example. Methods Mol Biol (2010) 0.84
Different functions of MdtB and MdtC subunits in the heterotrimeric efflux transporter MdtB(2)C complex of Escherichia coli. Biochemistry (2012) 0.82
In Pseudomonas aeruginosa ethidium bromide does not induce its own degradation or the assembly of pumps involved in its efflux. Biochem Biophys Res Commun (2004) 0.76
Christian Raetz: scientist and friend extraordinaire. Annu Rev Biochem (2013) 0.75